MyFinsight
Home
Blog
About
Proceeds from private
placement
$20,154K
Proceeds from maturities
and sales of...
$6,000K
(-60.89%↓ Y/Y)
Proceeds from purchases
under the employee...
$176K
Proceeds from issuances
of ordinary shares...
$137K
Net cash provided by
financing activities
$18,949K
(11525.15%↑ Y/Y)
Net cash provided by
(used in) investing...
$1,531K
(109.87%↑ Y/Y)
Effect of exchange rate
changes on cash and cash...
$117K
(-60.87%↓ Y/Y)
Canceled cashflow
$1,518K
Canceled cashflow
$4,469K
Net decrease in cash
and cash...
-$11,330K
(69.87%↑ Y/Y)
Canceled cashflow
$20,597K
Accrued liabilities
$2,657K
(1928.24%↑ Y/Y)
Share-based compensation
expense
$2,460K
(29.95%↑ Y/Y)
Prepaid expenses and
other current assets
-$2,373K
(-167.34%↓ Y/Y)
Depreciation and
amortization
$325K
(-5.52%↓ Y/Y)
Accounts payable
$52K
(-97.34%↓ Y/Y)
Other non-current
assets
-$3K
(-142.86%↓ Y/Y)
Payment of private
placement issuance costs
$1,518K
Purchases of short-term
investments
$4,469K
(-85.33%↓ Y/Y)
Net cash used in
operating activities
-$31,927K
(-41.58%↓ Y/Y)
Canceled cashflow
$7,870K
Net loss
-$36,682K
(-58.31%↓ Y/Y)
Accounts receivable, net
$2,923K
(470.47%↑ Y/Y)
Contract liabilities
-$167K
Accretion of discounts on
available-for-sale investments
$10K
(-98.14%↓ Y/Y)
Operating lease
liabilities
-$8K
(-114.29%↓ Y/Y)
Other non-current
liabilities
-$7K
(98.63%↑ Y/Y)
Back
Back
Cash Flow
Connect Biopharma Holdings Ltd (CNTB)
Connect Biopharma Holdings Ltd (CNTB)
source: myfinsight.com